20.213 Genome Stability and Engineering in the Context of Diseases, Drugs, and Public Health


Class Info

Studies how DNA damage leads to diseases, and how DNA repair modulates cancer risk and treatment. Also covers how DNA repair impacts genetic engineering, whether by targeted gene therapy or CRISPR-mediated genetic changes. Students gain a public health perspective by examining how DNA-damaging agents in our environment can lead to downstream cancer. Explores the underlying chemical, molecular and biochemical processes of DNA damage and repair, and their implications for disease susceptibility and treatment.

This class has 5.07, and 7.05 as prerequisites.

20.213 will be offered this semester (Spring 2018). It is instructed by B. P. Engelward.

Lecture occurs 10:00 AM to 12:00 PM on Mondays and Wednesdays in 56-191.

This class counts for a total of 6 credits.

You can find more information at the MIT + 20.213 - Google Search site.

MIT 20.213 Genome Stability and Engineering in the Context of Diseases, Drugs, and Public Health Related Textbooks
MIT 20.213 Genome Stability and Engineering in the Context of Diseases, Drugs, and Public Health On The Web

© Copyright 2015